Biopharma

ADRX

1 brief covering ADRX, most recent first.

  1. · IPO priced

    ADRX — IPO pricing analysis (2026-09-29)

    ADARx Pharmaceuticals priced its IPO at $17.00 per share — the top of the marketed range — and upsized the deal from an original 21.9 million shares to 26,250,000 shares, raising $446,250,000 in gross proceeds. Add th...

    Read brief →